Remix Therapeutics

Our Science
- Platform
- Pipeline
About Us
Join Us
News
Clinical Trials

Our Science
- Platform
- Pipeline
About Us
Join Us
News
Clinical Trials
Contact

Advisor Category: Advisors

Daniela Zarnescu

Steve Kelsey

Aaron Hoskins

Zaven Kaprielian

Christopher Burge

Posts navigation

Search

Recent Posts

Reprogramming RNA processing: an emerging therapeutic landscape
Remix Therapeutics™ to Present at 7th Annual Evercore HealthCONx Conference
Remix Therapeutics™ to Present Preclinical Data Demonstrating Anti-Leukemic Activity of REM-422 in AML at the 66th American Society of Hematology Annual Meeting and Exposition (ASH)
Transcriptome-wide splicing network reveals specialized regulatory functions of the core spliceosome
Remix Therapeutics™ Announces Publication in Science that Reveals Unprecedented Insights into Spliceosome Regulation and Alternative Splicing

Recent Comments

No comments to show.

Archives

January 2025
November 2024
October 2024
September 2024
August 2024
July 2024
June 2024
May 2024
February 2024
January 2024
December 2023
September 2023
May 2023
March 2023
January 2023
December 2022
September 2022
May 2022
March 2022
February 2022
January 2022
December 2021
August 2021
March 2021
January 2021
December 2020

Categories

News
Press Release
Publication

Remix Therapeutics

100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901

Our Science
About Us
Join Us
News
Clinical Trials
Contact

100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901

© 2023 Remix Therapeutics, Inc. All Rights Reserved